The Valcyte case is vital as it bars incremental innovation and recognises the right of patient groups to oppose patents. ...
http://business.rediff.com/column/2010/may/13/guest-why-roche-lost-a-patent-battle-in-india.htmSwiss drug multinational Roche AG suffered yet another setback in its ongoing patent fights in India after the Chennai patent office rejected its... ...
http://business.rediff.com/report/2010/may/06/patent-office-rejects-roche-claim-on-eye-drug.htmSwiss drug multinational Roche AG suffered yet another setback in its ongoing patent fights in India after the Chennai patent office rejected its... ...
http://sify.com/finance/patent-office-rejects-roche-claim-on-eye-drug-news-news-kfgbE9acige.htmlThe Swiss drug maker has the option of filing an appeal against the patent officeufffdufffdufffds decision on Valcyte with IPAB ...
http://www.livemint.com/2010/05/05224059/Roche8217s-patent-on-HIV-dr.html